Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05659732
What this trial is testing

PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer

Who this might be right for
Acute Myeloid LeukemiaLymphoma, Mantle-Cell
PharmaEngine 32
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Not applicableLooking for participantsNCT06947044
What this trial is testing

Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding

Who this might be right for
Acute LeukemiaAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukaemia
Donald Arnold 60
Early research (Phase 1)Ended earlyNCT06128044
What this trial is testing

CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Caribou Biosciences, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00358644
What this trial is testing

Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Eisai Inc. 55
Testing effectiveness (Phase 2)Looking for participantsNCT07304232
What this trial is testing

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 134
Large-scale testing (Phase 3)Study completedNCT01371981
What this trial is testing

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaLeukemia CutisMyeloid Neoplasm+1 more
National Cancer Institute (NCI) 1,645
Not applicableLooking for participantsNCT06472128
What this trial is testing

Novel Digital Application for Patients With Acute Leukemia

Who this might be right for
Relapsed Adult Acute Myeloid LeukemiaPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia
Massachusetts General Hospital 200
Post-approval studies (Phase 4)Study completedNCT03727750
What this trial is testing

Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML

Who this might be right for
ECGPharmacokineticsSafety
Pfizer 51
Early research (Phase 1)Ended earlyNCT04172844
What this trial is testing

Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Medical College of Wisconsin 16
Early research (Phase 1)Looking for participantsNCT07270978
What this trial is testing

Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasm
University of Virginia 23
Early research (Phase 1)Active Not RecruitingNCT02632708
What this trial is testing

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia (AML)Untreated AMLAML Arising From Myelodysplastic Syndrome (MDS)+2 more
Institut de Recherches Internationales Servier 153
Early research (Phase 1)WithdrawnNCT07566585
What this trial is testing

Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation

Who this might be right for
AML - Acute Myeloid LeukemiaAML With Mutated NPM1AML, Adult Recurrent
BlueSphere Bio, Inc
Testing effectiveness (Phase 2)Study completedNCT01297543
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more
Cellerant Therapeutics 45
Not applicableNot Yet RecruitingNCT05558943
What this trial is testing

Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 750
Early research (Phase 1)Study completedNCT00005785
What this trial is testing

Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer

Who this might be right for
Hematologic NeoplasmHIV Infection
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Looking for participantsNCT04581512
What this trial is testing

Study to Evaluate the Safety and Tolerability of EP0042

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes
Ellipses Pharma 70
Early research (Phase 1)Not Yet RecruitingNCT07780565
What this trial is testing

Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03747757
What this trial is testing

Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeCancer Fatigue+2 more
M.D. Anderson Cancer Center 48
Early research (Phase 1)Study completedNCT02141828
What this trial is testing

Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene

Who this might be right for
LeukemiaAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+1 more
Epizyme, Inc. 18
Next Page